Southwest Airlines is overhauling its business model by ending open seating to introduce new fees, mirroring its competitors' strategies. This industry-wide push for ancillary revenue could create growth for companies that supply airlines with premium cabin products and the technology to sell them.
Published on January 29
Southwest's historic policy change signals a major shift across the entire airline industry. This kind of fundamental business model evolution often creates significant opportunities for early investors.
Ancillary fees can dramatically boost airline profitability - sometimes adding billions in revenue. Companies enabling this transformation are positioned to benefit from this expanding market.
European carriers like Ryanair have shown how profitable the ancillary revenue model can be. Now US airlines are following suit, creating opportunities throughout the supply chain.
Southwest Airlines' historic shift away from open seating signals a major industry trend. Airlines are converging on fee-based services to maximise profitability, creating opportunities for companies that support cabin upgrades and revenue optimization systems.
This group includes both airlines implementing ancillary revenue strategies and the suppliers enabling these upgrades. It covers aircraft manufacturers, seating specialists, technology providers, and airlines pioneering premium service models across different market segments.
These companies were handpicked by professional analysts as key players in the ancillary revenue ecosystem. They represent the airlines driving this trend and the critical suppliers positioned to benefit from increased demand for cabin modernisation and revenue management technology.
This basket's total market capitalisation is 76,947.89 and is heavily anchored by large-cap stocks, giving it a generally stable profile that tends to track broader market movements.
DAL: $42.98B
UAL: $33.96B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
On average, analysts expect assets in this group to grow 12.68% over the next year.
2 of 5 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+12.68%
